WHO GRADE II GLIOMA
Clinical trials for WHO GRADE II GLIOMA explained in plain language.
Never miss a new study
Get alerted when new WHO GRADE II GLIOMA trials appear
Sign up with your email to follow new studies for WHO GRADE II GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach aims to protect scalp in brain tumor patients
Disease control OngoingThis study tests a precise radiation therapy that targets brain tumors while sparing the scalp to reduce wound infections and other side effects. About 100 adults with newly diagnosed grade II to IV gliomas will receive this treatment. The goal is to see if this approach is safer…
Matched conditions: WHO GRADE II GLIOMA
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
New pill shows promise for untreated brain tumors
Disease control OngoingThis study tests a new drug, DS-1001b, in 25 people with a slow-growing brain tumor (grade II glioma) that has a specific gene change (IDH1 mutation). Participants have not had chemotherapy or radiation before. The goal is to see if the drug can shrink the tumor and how safe it i…
Matched conditions: WHO GRADE II GLIOMA
Phase: PHASE2 • Sponsor: Daiichi Sankyo Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for young brain tumor patients: drug duo targets hard-to-treat gliomas
Disease control OngoingThis early-stage study tests a new drug (BGB-290) combined with chemotherapy (temozolomide) in adolescents and young adults with IDH-mutant gliomas, a type of brain tumor. The goal is to find the safest dose and check for side effects. About 78 participants with newly diagnosed o…
Matched conditions: WHO GRADE II GLIOMA
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 14, 2026 12:04 UTC